Sun Pharma gains after strong Q3 outcome

Sun Pharmaceutical Industries rose 1.3% to Rs 619 at 15:03 IST on BSE after consolidated net profit surged 73.73% to Rs 1531.09 crore on 51.59% increase in total income to Rs 4446.82 crore in Q3 December 2013 over Q3 December 2012.

Sun Pharmaceutical Industries declared the Q3 result during market hours today, 13 February 2014.

Meanwhile, the BSE Sensex was down 231.11 points, or 1.13%, to 20,217.38

On BSE, so far 2.24 lakh shares were traded in the counter compared with average volume of 1.32 lakh shares in the past one quarter.

The stock hit a high of Rs 623.50 and low of Rs 613 so far during the day. The stock hit a record high of Rs 650 on 10 October 2013. The stock hit a 52-week low of Rs 373.50 on 12 February 2013.

The stock had outperformed the market over the past one month till 12 February 2014, rising 0.22% compared with the Sensex's 1.49% fall. The scrip also outperformed the market in past one quarter, rising 2.16% as against Sensex's 0.82% rise.

The large-cap company has an equity capital of Rs 207.12 crore. Face value per share is Re 1.

Sun Pharmaceutical Industries is an international specialty pharmaceutical company with over 72% sales from global markets. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in US, India and several other markets across the world.

Powered by Capital Market - Live News